ALB and hepatocellular carcinoma: The liver disease component has recently been modified by inclusion of the semi-quantitative ALBI (albumin and bilirubin) score [7], as well as the independent role in prognosis that systemic inflammation has been shown to have for many tumor types, including HCC, as measured by the serum levels of C-reactive protein and albumin in the Glasgow score [8].